Today, we are happy to officially announce our new partnership with Schrödinger.
In order to foster digital innovation, we intend to combine our efforts to boost entrepreneurial, innovative thinking and acting in the chemical and health sectors.
Schrödinger’s industry-leading computational platform to accelerate drug discovery and materials design is deployed by leading biopharmaceutical, chemical, and electronics companies worldwide. In addition to this global business, Schrödinger has built a robust pipeline of drug discovery programs, internally and through collaborations, and has co-founded leading biotech companies, including Nimbus Therapeutics. Schrödinger’s significant and ongoing investment in basic research continues to drive advances in its computational platform. Founded in 1990, Schrödinger has over 400 employees in its New York City headquarters and around the world. Visit schrodinger.com for more information.
Supporting and connecting startups, corporates and venture capitalists – this is the mission of our Digital Hub. Through this network, we aim to create “an ecosystem for digital innovation” that allows various players to benefit from each other. Thanks to the partnership with Schrödinger, we can strengthen this vision.
We are looking forward to creating new exciting collaborations.